GLOW for Gut Health: What the Evidence Shows
What human and animal studies show about GLOW for gut health, how strong that evidence is, and what is still unproven.
- Strongest evidence
- Animal
- from an ingredient's studies
- Human studies
- None found
- with an outcome for gut health, in our evidence file (PubMed search, 11 Oct 2026)
- Animal studies
- 5
- with an outcome for gut health, in our evidence file (PubMed search, 11 Oct 2026)
- Studies we summarised
- 5
- with an outcome for gut health
Evidence for gut health
Each row is an outcome related to gut health from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here. No study has tested GLOW itself; rows are for each ingredient.
| Outcome | Result | Study type | Source |
|---|---|---|---|
| GHK-Cu: Colitis severity and mucosal repair | GHK-Cu reduced weight loss, disease activity and colonic inflammatory damage and promoted mucosal repair in DSS colitis mice. | Animal · mouse (plus mouse cell co-culture) (not a human result) | Frontiers in pharmacology 2025, PMID 40672369 |
| BPC-157: Ischemic colon blood supply | In rats with ischemic colitis, BPC 157 restored blood supply to the injured colon and activated collateral vessels. | Animal · rat (not a human result) | World journal of gastroenterology 2017, PMID 29358856 |
| BPC-157: Colitis and anastomosis healing | Control rats did not heal; BPC 157 induced healing of both cysteamine colitis and colon-colon anastomosis. | Animal · rat (not a human result) | Journal of physiology and pharmacology 2013, PMID 24304574 |
| BPC-157: Fistula healing | BPC 157 given by injection or by mouth accelerated healing of the colon and skin defects and closed the fistula. | Animal · rat (not a human result) | Journal of pharmacological sciences 2008, PMID 18818478 |
| BPC-157: Gastric ulcer | BPC 157 given intramuscularly or intragastrically reduced ulcer area and accelerated ulcer healing in rats; intramuscular dosing was better than intragastric. | Animal · rat (not a human result) | World journal of gastroenterology 2004, PMID 15052688 |
GLOW and gut health are not in our PubMed count ledger yet; the rows above come from our evidence file (PubMed search, 11 Oct 2026). Grades follow our .
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
What the digestive system is
MedlinePlus describes the digestive system as a series of hollow organs joined in a long, twisting tube.[6]
Gut studies in rodents, by component
GHK-Cu showed significant therapeutic effects in a dextran sulfate model of ulcerative colitis in mice, according to the authors (animal study of one GLOW component).[1]
In rats, BPC-157 was reported to heal cysteamine colitis and a colon-to-colon join at the same time, where controls could not (animal study).[3]
BPC-157 was reported to speed closure of colon-to-skin fistulas in rats whether given by injection or by mouth (animal study).[4]
In rat gastric ulcer models, injected and tube-fed BPC-157 were each reported to ameliorate acute ulcers (animal study).[5]
Rats with blocked colon blood supply were treated with a BPC-157 bath, and the authors concluded it quickly restored blood supply to the injured area (animal study).[2]
Human evidence for gut health
All 5 cached studies behind this page are animal studies, so it holds 0 human gut outcomes for GLOW or its three components.
Calculated from human outcomes 0; animal outcomes 5; cached studies 40672369, 24304574, 18818478, 29358856, 15052688. Formula: count of human-participant studies among the cached set = 0
One title notes that BPC 157 is in clinical trials for inflammatory bowel disease (PL14736), but the abstract reports rat results only.[4]
Other peptides people research for gut health
All peptides for gut health, comparedCommon questions
Does GLOW help with gut health?
The strongest study we summarise for gut health is animal evidence, for an ingredient rather than the blend, across 5 studies with an outcome for gut health. That is not proof it works in people.
Is GLOW approved for gut health?
No. GLOW is not FDA approved for any use, including gut health.
What is the best peptide for gut health?
There is no single answer. Our gut health overview compares each candidate by evidence grade and legal status rather than by popularity.
Is GLOW peptide good for gut health?
No. The cached evidence is limited to rodent studies of single components, and none of it tests the GLOW blend in people.
Calculated from human outcomes 0; animal outcomes 5. Formula: human outcomes in cached set = 0
More on GLOW
Sources
- 1Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms.Frontiers in pharmacology · 2025PMID 40672369Accessed 2 Oct 2026
- 2Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights.World journal of gastroenterology · 2017PMID 29358856Accessed 2 Oct 2026
- 3Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability.Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2013PMID 24304574Accessed 2 Oct 2026
- 4Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system.Journal of pharmacological sciences · 2008PMID 18818478Accessed 2 Oct 2026
- 5Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats.World journal of gastroenterology · 2004PMID 15052688Accessed 2 Oct 2026
- 6medlineplus.gov pagemedlineplus.gov · web pagemedlineplus.gov
Found an error? Report a correction.